Denali Therapeutics

Associate Director, Risk Management

Denali Therapeutics$171K — $223K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree with 12+ years GCP Quality Assurance experience, Master's with 10+, or PhD with 7+; equivalent experience may be accepted.
  • Expertise in ICH E6 GCP, GVP, FDA regulations, and global regulatory requirements.
  • Experience with Quality by Design (QbD), Risk-Based Quality Management (RBQM), and Quality Management System (QMS) principles.
  • Proven track record in leading GCP deviation, CAPA, vendor qualification, and quality risk management.
  • Strong analytical skills to evaluate complex quality risks and identify trends.
  • Excellent communication skills to influence and collaborate with cross-functional teams.
  • Capacity to manage multiple priorities in a fast-paced environment.

Responsibilities

  • Lead GCP deviation and CAPA processes from investigation to closure.
  • Collaborate with study teams to assess and mitigate quality risks using risk management principles.
  • Act as a subject matter expert on GCP quality risk management and guide teams on noncompliance issues.
  • Oversee the Clinical Trial Risk Tracking Program for proper risk documentation and monitoring.
  • Analyze compliance data, identify trends, and provide actionable insights to leadership.
  • Review quality events to uncover systemic risks and initiate improvement initiatives.
  • Direct vendor qualification and oversight activities to ensure compliance with regulations.
  • Support regulatory inspections by ensuring documentation readiness and response preparation.

Benefits

  • 401k plan
  • Healthcare coverage
  • Employee Stock Purchase Plan (ESPP)
  • Broad range of additional benefits
Full Job Description
Serves as a subject matter expert in Quality Risk Management, partnering with GCP and GVP Quality colleagues and cross-functional development teams to proactively identify, assess, and mitigate quality risks across Denali's clinical development programs. Strengthens quality oversight by driving risk-based decision making, ensuring regulatory compliance, and advancing a culture of continuous improvement. Leads quality risk management processes, metrics, and vendor oversight activities that support inspection readiness and the successful execution of clinical trials. Key Accountabilities / Core Job Responsibilities • Lead the GCP deviation and CAPA processes, ensuring timely investigation, implementation, effectiveness verification, and closure. • Partner with study teams to identify, assess, and mitigate quality risks across clinical development programs using Quality by Design and risk-based quality management principles. • Serve as the subject matter expert on GCP quality risk management, providing guidance on the detection, investigation, documentation, and resolution of GCP noncompliance. • Maintain quality oversight of the Clinical Trial Risk Tracking Program and ensure risks are appropriately documented, monitored, and escalated. • Analyze quality and compliance data, identify trends, develop meaningful metrics, and communicate insights and recommendations to leadership and cross-functional stakeholders. • Review deviations, noncompliance, and quality events across development programs to identify systemic risks and drive continuous improvement initiatives. • Lead GCP and GVP vendor qualification and ongoing quality oversight activities to ensure compliance with applicable regulatory requirements and company standards. • Support regulatory inspections and audits through inspection readiness activities, documentation review, response development, and follow-up actions. • Contribute to the ongoing enhancement of the Quality Management System (QMS) by improving quality risk management processes, tools, and best practices. Qualifications / Skills • Typically requires a Bachelor's degree with 12+ years of relevant GCP Quality Assurance experience, a Master's degree with 10+ years of relevant experience, or a PhD with 7+ years of relevant experience; or an equivalent combination of education and experience. • Demonstrated expertise in ICH E6 Good Clinical Practice (GCP), Good Pharmacovigilance Practice (GVP), FDA regulations, and other applicable global regulatory requirements. • Experience applying Quality by Design (QbD), Risk-Based Quality Management (RBQM), and Quality Management System (QMS) principles within clinical development. • Experience leading GCP deviation, CAPA, vendor qualification, and quality risk management processes in a GxP-regulated environment. • Strong analytical and critical thinking skills with the ability to evaluate complex quality risks, identify trends, and develop practical, risk-based solutions. • Excellent written, verbal, and interpersonal communication skills with demonstrated ability to influence and collaborate across cross-functional teams without direct authority. • Ability to manage multiple priorities in a dynamic, fast-paced environment while maintaining a high level of quality, accuracy, and attention to detail. Salary Range: $171,000.00 to $223,000.00 . Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Denali offers a competitive total rewards package, which includes a 401k, healthcare coverage, ESPP and a broad range of other benefits. Learn more at https://www.denalitherapeutics.com/careers This compensation and benefits information is based on Denali’s good faith estimate as of the date of publication and may be modified in the future.

About Denali Therapeutics

Denali Therapeutics is a biotechnology company focused on developing therapies for neurodegenerative diseases. The company's pipeline includes treatments for Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Denali Therapeutics uses a proprietary technology platform to develop drugs that can cross the blood-brain barrier, which is a major challenge in treating neurological disorders. The company was founded by a team of scientists with extensive experience in drug development and neuroscience research.
Learn more about Denali Therapeutics
Size
380 employees
Market Cap
$3.7 billion
Industry
Net Income
$71.1 million
Founded
2015
Revenue
$335.6 million
NASDAQ

Similar Jobs

More Jobs at Denali Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Associate Director, Risk Management jobs: